Domestic business of Rallis India jumps 35 per cent in Q3FY20

Rallis India, a chemical manufacturing company and a subsidiary of Tata Chemicals, reported its numbers for the quarter ended December 31, 2019.

The consolidated revenue for the quarter Q3FY20 came in at Rs 533.6 crore, as against Rs 417.35 crore in the corresponding quarter last year, registering 27.9 per cent YoY increase. In this quarter, domestic business grew by 35 per cent YoY and international sales by 24 per cent YoY.

EBITDA for the quarter grew by 101.7 per cent YoY to Rs 55.74 crore as against Rs 27.63 crore in the corresponding quarter last year, with a corresponding margin expansion of 383 bps. EBITDA margin for the quarter stood at 10.4 per cent.

PAT for the quarter came in at Rs 38.05 crore as against Rs 13.76 crore in the corresponding quarter last year, with a YoY increase of 176.5 per cent.

During the quarter, company introduced two new formulations-Sarthak and Impeder. Looking at the expansion front, Metribuzin Phase II expansion of 500 MTPA is expected to be commercialised by February 1, 2020.

On Friday, the stock of Rallis India jumped by nearly 15 per cent in the early trade and made an intraday high of Rs 222.15 on the BSE.